Next Article in Journal
Development of Microsatellite Markers for the Korean Mussel, Mytilus coruscus (Mytilidae) Using Next-Generation Sequencing
Next Article in Special Issue
Mechanisms of Ovarian Cancer Metastasis: Biochemical Pathways
Previous Article in Journal
Direct Observation of Protein Microcrystals in Crystallization Buffer by Atmospheric Scanning Electron Microscopy
Previous Article in Special Issue
Transforming Growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): A Matrix Protein with Dual Functions in Ovarian Cancer
Article Menu

Export Article

Open AccessReview
Int. J. Mol. Sci. 2012, 13(8), 10568-10582;

Deciphering the Molecular Nature of Ovarian Cancer Biomarker CA125

Adelaide Proteomics Centre, School of Molecular and Biomedical Science, University of Adelaide, Adelaide, SA 5005, Australia
Research Centre for Reproductive Health, Robinson Institute, University of Adelaide, Adelaide, SA 5005, Australia
These authors contributed equally to this work.
Author to whom correspondence should be addressed.
Received: 2 July 2012 / Revised: 3 July 2012 / Accepted: 13 August 2012 / Published: 22 August 2012
(This article belongs to the Special Issue Cancer Molecules in Ovarian Cancer 2012)
Full-Text   |   PDF [1013 KB, uploaded 19 June 2014]


The ovarian cancer biomarker CA125 has been extensively investigated over the last 30 years. The knowledge about the exact molecular nature of this protein, however, remains fragmented. This review provides an overview of the structural research regarding CA125, and presents an orthogonal verification method to confirm the identity of this molecule. The need for independent identification of CA125 is exemplified by several reports where mutually exclusive data concerning the existence of isoforms and the glycan moieties is presented. Mass spectrometry can overcome the pitfalls of a single detection/identification method such as antibody probing. Independent verification of CA125 identity in characterization studies will help establish a refined model of its molecular structure that will promote the development of new approaches for diagnosis, prognosis and therapy of ovarian cancer. View Full-Text
Keywords: CA125; MUC16; ovarian cancer; biomarker; mass spectrometry CA125; MUC16; ovarian cancer; biomarker; mass spectrometry
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Weiland, F.; Martin, K.; Oehler, M.K.; Hoffmann, P. Deciphering the Molecular Nature of Ovarian Cancer Biomarker CA125. Int. J. Mol. Sci. 2012, 13, 10568-10582.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top